Mindleap Health Implements HIPAA Compliance Standards and Appoints Former Canadian Ministry of Health Telemedicine Expert as Head of Program Management
17 sept. 2020 07h30 HE
|
Mydecine Innovations Group Inc.
DENVER, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group, Inc. (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), is pleased to announce that its wholly-owned...
Mydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related Assets
15 sept. 2020 07h00 HE
|
Mydecine Innovations Group Inc.
DENVER, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine" or the "Company"), today announced the Company has formed a special committee...
Mydecine Innovations Group Would Like to Give Thanks to its Shareholders for Extending the Lockup on the Five Cent Placement for Another 120 Days
03 sept. 2020 15h17 HE
|
Mydecine Innovations Group Inc.
DENVER, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine", “MIG” or the "Company") is pleased to announce that its shareholders have...
Mydecine Innovations Group Announces Extended Lock-Up Arrangement
25 août 2020 13h40 HE
|
Mydecine Innovations Group Inc.
DENVER, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine" or the "Company"), today announced that it has engaged with certain...
Mydecine™ Launches World's First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise
18 août 2020 07h30 HE
|
Mydecine Innovations Group Inc.
DENVER, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine™" or the "Company") is pleased to announce it is the first organization to...
Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD
13 août 2020 07h37 HE
|
Mydecine Innovations Group Inc.
DENVER, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine" or the "Company"), is pleased to announce that NeuroPharm Inc., a company...
Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector
12 août 2020 07h30 HE
|
Mydecine Innovations Group Inc.
DENVER, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine" “MIG” or the "Company"), is pleased to provide a corporate update regarding...
Mindleap Health™ Expands its Digital Mental Health Programs for Addiction, Psychedelic Integration and Holistic Wellness
04 août 2020 07h30 HE
|
Mydecine Innovations Group Inc.
DENVER, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group™ (CSE: MYCO) (OTC: NLBIF) (FSE:0NF) ("Mydecine"), is pleased to announce that its subsidiary, Mindleap Health™ (“Mindleap” or the...